Jpmorgan Chase & CO Inotiv, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Inotiv, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 135 shares of NOTV stock, worth $550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
135
Previous 235
42.55%
Holding current value
$550
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding NOTV
# of Institutions
52Shares Held
3.67MCall Options Held
1.1KPut Options Held
21.3K-
Vanguard Group Inc Valley Forge, PA1.05MShares$4.29 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN268KShares$1.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA251KShares$1.02 Million0.0% of portfolio
-
Kpp Advisory Services LLC Louisville, KY238KShares$969,8890.1% of portfolio
-
Black Rock Inc. New York, NY213KShares$868,1660.0% of portfolio
About Inotiv, Inc.
- Ticker NOTV
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 25,594,500
- Market Cap $104M
- Description
- Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...